Effects of Vildagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on the Parameters of Glucose Metabolism and the Cardio-Ankle Vascular Index in Individuals with Type 2 Diabetes

Effects of Vildagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on the Parameters of Glucose Metabolism and the Cardio-Ankle Vascular Index in Individuals with Type 2 Diabetes

DPP-4 inhibitors are frequently used as first-line agents for the treatment of type 2 diabetes in Japan. This study aimed to examine the effects of vildagliptin on glucose metabolism and arterial stiffness. Twenty treatment-naïve patients with type 2 diabetes (8 males and 12 females) received vildag...

Full description

Bibliographic Details
Main Authors: Daiji Nagayama, Hidetoshi Kawana, Yasuhiro Watanabe, Osamu Horikawa, Masahiro Ohira, Atsuhito Saiki
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Journal of Clinical Medicine
Subjects:
vildagliptin
dipeptidyl peptidase-4 inhibitor
cardio-ankle vascular index
glycemic variability
Online Access:https://www.mdpi.com/2077-0383/13/2/481

Internet

https://www.mdpi.com/2077-0383/13/2/481

Similar Items